Finweek English Edition - - INVESTMENT -

Ci­pla Med­pro re­sults came in as ex­pected, show­ing in­creased rev­enue cou­pled with de­creased earn­ings. But Jean-Pierre Ver­ster of 36One As­set Man­age­ment pointed me to a po­ten­tial op­por­tu­nity here for those pre­pared to take a lit­tle risk. Ci­pla In­dia has a R10 of­fer on the ta­ble and the doc­u­ments will shortly be sent to share­hold­ers. Bar­ring any un­fore­seen hitches, the delist­ing should be hap­pen­ing in about six months’ time at that R10 mark. Yet the price of Ci­pla Med­pro drops down to around 920c ev­ery so of­ten, so a buyer at 920c will get R10 in about six months. As­sum­ing one can keep the trans­ac­tion fees low enough, that could make around 8% profit, which is a very solid re­turn for a

Newspapers in English

Newspapers from South Africa

© PressReader. All rights reserved.